We examined a total of 51 germinomas and 1 mixed GCT (germinoma and teratoma component) for mutations in KIT exons 11, 13, 17 and 18 as well as mutation hotspots in HRAS, KRAS, NRAS and RRAS-2. This evidence concerns the gene KRAS and granular cell tumor.